PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
2024 Geetha, D; Dua, A; Yue, H; Springer, J; Salvarani, C; Jayne, D; Merkel, P; Pieruzzi, F
Interpretation of GFR slope in untreated and treated adult Fabry patients
2024 Pisani, A; Pieruzzi, F; Cirami, C; Riccio, E; Mignani, R
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study
2024 Ajello, E; Arresta, A; Rutili, R; Aronica, S; Lorenzo, R; Monti, E; Galletti, M; Cannizzo, L; Giannini, L; Lucchini, A; Pieruzzi, F; Elli, S
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study
2024 Mignani, R; Americo, C; Aucella, F; Battaglia, Y; Cianci, V; Sapuppo, A; Lanzillo, C; Pennacchiotti, F; Tartaglia, L; Marchi, G; Pieruzzi, F
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study
2023 Camporeale, A; Bandera, F; Pieroni, M; Pieruzzi, F; Spada, M; Bersano, A; Econimo, L; Lanzillo, C; Rubino, M; Mignani, R; Motta, I; Olivotto, I; Tanini, I; Valaperta, R; Chow, K; Baroni, I; Boveri, S; Graziani, F; Pica, S; Tondi, L; Guazzi, M; Lombardi, M
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis
2023 Moroni, A; Tondi, L; Milani, V; Pieroni, M; Pieruzzi, F; Bevilacqua, F; Pasqualin, G; Chow, K; Pica, S; Lombardi, M; Camporeale, A
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study
2023 Genovesi, S; Porcu, L; Rebora, P; Slaviero, G; Casu, G; Bertoli, S; Airoldi, F; Buskermolen, M; Gallieni, M; Pieruzzi, F; Rovaris, G; Montoli, A; Piccaluga, E; Molon, G; Alberici, F; Adamo, M; Gaspardone, A; D'Angelo, G; Merella, P; Vezzoli, G; Trezzi, B; Mazzone, P
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
2023 Cortazar, F; Niles, J; Jayne, D; Merkel, P; Bruchfeld, A; Yue, H; Schall, T; Bekker, P; Peh, C; Chakera, A; Cooper, B; Kurtkoti, J; Langguth, D; Levidiotis, V; Luxton, G; Mount, P; Mudge, D; Noble, E; Phoon, R; Ranganathan, D; Ritchie, A; Ryan, J; Suranyi, M; Rosenkranz, A; Lhotta, K; Kronbichler, A; Demoulin, N; Bovy, C; Hellemans, R; Hougardy, J; Sprangers, B; Wissing, K; Pagnoux, C; Barbour, S; Brachemi, S; Cournoyer, S; Girard, L; Laurin, L; Liang, P; Philibert, D; Walsh, M; Tesar, V; Becvar, R; Horak, P; Rychlik, I; Szpirt, W; Dieperink, H; Gregersen, J; Ivarsen, P; Krarup, E; Lyngsoe, C; Rigothier, C; Augusto, J; Belot, A; Chauveau, D; Cornec, D; Jourde-Chiche, N; Ficheux, M; Karras, A; Klein, A; Maurier, F; Mesbah, R; Moranne, O; Neel, A; Quemeneur, T; Saadoun, D; Terrier, B; Zaoui, P; Schaier, M; Benck, U; Bergner, R; Busch, M; Floege, J; Grundmann, F; Haller, H; Haubitz, M; Hellmich, B; Henes, J; Hohenstein, B; Hugo, C; Iking-Konert, C; Arndt, F; Kubacki, T; Kotter, I; Lamprecht, P; Lindner, T; Halbritter, J; Mehling, H; Schonermarck, U; Venhoff, N; Vielhauer, V; Witzke, O; Szombati, I; Szucs, G; Garibotto, G; Alberici, F; Brunetta, E; Dagna, L; De Vita, S; Emmi, G; Gabrielli, A; Manenti, L; Pieruzzi, F; Roccatello, D; Salvarani, C; Dobashi, H; Atsumi, T; Fujimoto, S; Hagino, N; Ihata, A; Kaname, S; Kaneko, Y; Katagiri, A; Katayama, M; Kirino, Y; Kitagawa, K; Komatsuda, A; Kono, H; Kurasawa, T; Matsumura, R; Mimura, T; Morinobu, A; Murakawa, Y; Naniwa, T; Nanki, T; Ogawa, N; Oshima, H; Sada, K; Sugiyama, E; Takeuchi, T; Taki, H; Tamura, N; Tsukamoto, T; Yamagata, K; Yamamura, M; van Daele, P; Rutgers, A; Teng, Y; Walker, R; Chua, I; Collins, M; Rabindranath, K; de Zoysa, J; Svensson, M; Grevbo, B; Kalstad, S; Little, M; Clarkson, M; Molloy, E; Pamplona, I; Anton, J; Lucia, V; Ciggaran, S; Cid, M; Encarnacion, M; Oliveras, X; Soler, M; Rusinol, H; Praga, M; Porras, L; Segarra, A; Bruchfeld, A; Segelmark, M; Soveri, I; Thomaidi, E; Westman, K; Neumann, T; Burnier, M; Daikeler, T; Dudler, J; Hauser, T; Seeger, H; Vogt, B; Jayne, D; Burton, J; Al Jayyousi, R; Amin, T; Andrews, J; Baines, L; Brogan, P; Dasgupta, B; Doulton, T; Flossmann, O; Griffin, S; Harper, J; Harper, L; Kidder, D; Klocke, R; Lanyon, P; Luqmani, R; Mclaren, J; Makanjuola, D; Mccann, L; Nandagudi, A; Selvan, S; O'Riordan, E; Patel, M; Patel, R; Pusey, C; Rajakariar, R; Robson, J; Robson, M; Salama, A; Smyth, L; Sznajd, J; Taylor, J; Merkel, P; Sreih, A; Belilos, E; Bomback, A; Carlin, J; Chen Lin, Y; Derebail, V; Dragoi, S; Dua, A; Forbess, L; Geetha, D; Gipson, P; Gohh, R; Greenwood, G; Hugenberg, S; Jimenez, R; Kaskas, M; Kermani, T; Kivitz, A; Koening, C; Langford, C; Marder, G; Mohamed, A; Monach, P; Neyra, N; Niemer, G; Niles, J; Obi, R; Owens, C; Parks, D; Podoll, A; Rovin, B; Sam, R; Shergy, W; Silva, A; Specks, U; Spiera, R; Springer, J; Striebich, C; Swarup, A; Thakar, S; Tiliakos, A; Tsai, Y; Waguespack, D; Wasko, M
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease
2022 Germain, D; Altarescu, G; Barriales-Villa, R; Mignani, R; Pawlaczyk, K; Pieruzzi, F; Terryn, W; Vujkovac, B; Ortiz, A
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148)
2022 Salerno, F; Roggero, L; Rossi, F; Binaggia, A; Bertoli, S; Pieruzzi, F
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence?
2022 Lacetera, R; Roggero, L; Vercelloni, P; Uzzo, M; Carbone, M; Invernizzi, P; L'Imperio, V; Pieruzzi, F; Sinico, R
Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy
2022 Salerno, F; Roggero, L; Rossi, F; Binaggia, A; Bertoli, S; Pieruzzi, F
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
2022 Mignani, R; Pieruzzi, F
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease
2022 Grassi, G; Fowler, B; Scali, B; Rossi, F; Motto, E; Pieruzzi, F; Mancia, G
Trabecular complexity as an early marker of cardiac involvement in Fabry disease
2022 Camporeale, A; Moroni, F; Lazzeroni, D; Garibaldi, S; Pieroni, M; Pieruzzi, F; Lusardi, P; Spada, M; Mignani, R; Burlina, A; Carubbi, F; Econimo, L; Battaglia, Y; Graziani, F; Pica, S; Chow, K; Camici, P; Lombardi, M
α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response
2022 Consolato, F; De Fusco, M; Schaeffer, C; Pieruzzi, F; Scolari, F; Gallieni, M; Lanzani, C; Feriozzi, S; Rampoldi, L
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease
2021 Fogazzi, G; Garigali, G; Pieruzzi, F; Corbelli, A; Fiordaliso, F; Consonni, D; Messa, P
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients
2021 Prota, C; Ferraioli, D; Iuliano, G; Pucci, M; Radano, I; Bottiglieri, P; Favalli, V; Pieruzzi, F; Galasso, G; Vecchione, C; Citro, R
Avacopan for the treatment of ANCA-associated vasculitis
2021 Jayne, D; Merkel, P; Schall, T; Bekker, P; Pieruzzi, F
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5)
2021 Genovesi, S; Porcu, L; Slaviero, G; Casu, G; Bertoli, S; Sagone, A; Buskermolen, M; Pieruzzi, F; Rovaris, G; Montoli, A; Oreglia, J; Piccaluga, E; Molon, G; Gaggiotti, M; Ettori, F; Gaspardone, A; Palumbo, R; Viazzi, F; Breschi, M; Gallieni, M; Contaldo, G; D'Angelo, G; Merella, P; Galli, F; Rebora, P; Valsecchi, M; Mazzone, P